Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext TRANSCRIPT
Download PDFApr 28, 2020
Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19. Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to...
Apr 28, 2020
Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19. Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to...
Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex TRANSCRIPT
Download PDFApr 27, 2020
Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer. Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like...
Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex
Apr 27, 2020
Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer. Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like...
Apr 23, 2020
Dr. John Poothullil is an expert on diabetes and author with many books on the subject of diabetes, cancer, and diet. He shares insights about why type 2 diabetes is considered such a high risk factor for COVID-19 and how the coronavirus attacks the body. He also discusses the challenges of identifying the correct...